NCT05358119 (MUSLOC) is a clinical trial in COVID-19, sponsored by University of Leeds.

Who is sponsoring NCT05358119?

NCT05358119 is sponsored by University of Leeds.

What condition does NCT05358119 study?

NCT05358119 studies COVID-19, Musculoskeletal Pain.

Is NCT05358119 still recruiting?

NCT05358119 is currently status unknown. Last updated 3 May 2022.

Last reviewed 2022-05-03 · How we verify

NCT05358119: MUSLOC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Musculoskeletal Pain in Long COVID

Status unknown Last updated 3 May 2022

What this trial tests

trial in COVID-19 in 100 participants. Status unknown.

Timeline

30 April 2022

Primary endpoint
1 October 2024

31 December 2024

Quick facts

Lead sponsor	University of Leeds
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	30 April 2022
Primary completion	1 October 2024
Estimated completion	31 December 2024
Sites	2 locations across United Kingdom

Conditions studied

COVID-19 — all drugs for COVID-19 →
Musculoskeletal Pain — all drugs for Musculoskeletal Pain →

Sponsor

University of Leeds

Who can join

18 and older, any sex, with COVID-19 or Musculoskeletal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Long COVID is a new disease, with musculoskeletal pain being one of the common presenting symptoms. This longitudinal study will explore the long COVID musculoskeletal pain aetiology, pathophysiology, impact on function and quality of life, prognosis and its natural evolution.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies.
Zadeh FH, Wilson DR, Agrawal DK. · · 2023 · cited 36× · PMID 37388279 · DOI 10.26502/ami.93650103
Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study.
Khoja O, Silva-Passadouro B, Cristescu E, McEwan K, et al · · 2024 · cited 8× · PMID 39100135 · DOI 10.2147/jpr.s466294
New-Onset Chronic Musculoskeletal Pain Following COVID-19 Infection Fulfils the Fibromyalgia Clinical Syndrome Criteria: A Preliminary Study.
Khoja O, Mulvey M, Astill S, Tan AL, et al · · 2024 · cited 7× · PMID 39335454 · DOI 10.3390/biomedicines12091940

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other University of Leeds trials

Trials by the same sponsor.

NCT07488143 — AI-assisted Continuous Stratification in Neurorehabilitation of Stroke Using Personalized Digital Twins · NA · not yet recruiting
NCT07409363 — Non-invasive Vagus Nerve Stimulation for Chronic Musculoskeletal Pain · NA · not yet recruiting
NCT07247812 — tSCS in Children and Young People With HCP · NA · not yet recruiting
NCT07181915 — Changing Outcomes Through Achievement Emails in COPD Using Routine Healthcare Audits · NA · active not recruiting
NCT06240403 — Digoxin and Senolysis in Heart Failure and Diabetes Mellitus · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05358119 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Leeds
Last refreshed: 3 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05358119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing